BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7786918)

  • 41. Uptake of technetium-99m-teboroxime in cultured myocardial cells: comparison with thallium-201 and technetium-99m-sestamibi.
    Maublant JC; Moins N; Gachon P; Renoux M; Zhang Z; Veyre A
    J Nucl Med; 1993 Feb; 34(2):255-9. PubMed ID: 8429344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-body imaging of thallium-201 after six different stress regimens.
    Pennell DJ; Ell PJ
    J Nucl Med; 1994 Mar; 35(3):425-8. PubMed ID: 8113888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Advantages of SPECT versus planar technique in nuclear cardiology].
    Bóveda FJ; González A; Azkona MS; Molinero E; Ayerbe P; Iriarte M
    Rev Esp Cardiol; 1994; 47 Suppl 4():124-31. PubMed ID: 7863077
    [No Abstract]   [Full Text] [Related]  

  • 44. Improved detection of viable myocardium with thallium-201 reinjection in chronic coronary artery disease: comparison with technetium-99m-MIBI imaging.
    Maurea S; Cuocolo A; Nicolai E; Salvatore M
    J Nucl Med; 1994 Apr; 35(4):621-4. PubMed ID: 8151385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise.
    Lee J; Chae SC; Lee K; Heo J; Iskandrian AS
    J Nucl Med; 1994 Apr; 35(4):535-41. PubMed ID: 8151371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Myocardial scintigraphy with technetium 99m methoxyisobutylisonitrile. A comparison with coronary arteriography in patients with suspected ischemic cardiopathy].
    Pace L; Cuocolo A; Nappi A; Nicolai E; Imbriaco M; Mangoni di Santo Stefano ML; Salvatore M
    Radiol Med; 1992; 83(1-2):97-100. PubMed ID: 1557552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols.
    Berman DS; Kiat HS; Van Train KF; Germano G; Maddahi J; Friedman JD
    J Nucl Med; 1994 Apr; 35(4):681-8. PubMed ID: 8151394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety of different dosages of intravenous adenosine used in conjunction with diagnostic myocardial imaging techniques.
    Mohiuddin SM; Esterbrooks DJ; Gupta NC; Hilleman DE
    Pharmacotherapy; 1993; 13(5):476-80. PubMed ID: 8247915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tracer selection with different stress modalities based on tracer kinetics.
    Heller GV
    J Nucl Cardiol; 1996; 3(6 Pt 2):S15-21. PubMed ID: 8989682
    [No Abstract]   [Full Text] [Related]  

  • 51. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST; Leppo JA
    Cardiol Clin; 1994 May; 12(2):169-85. PubMed ID: 8033171
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radionuclide methods of identifying patients who may require coronary artery bypass surgery.
    Beller GA; Gibson RS; Watson DD
    Circulation; 1985 Dec; 72(6 Pt 2):V9-22. PubMed ID: 3905063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stress myocardial scintigraphy in the pre- and postoperative diagnosis of ischemic cardiopathy. The correlations between the clinical aspects and the coronary angiographic picture].
    Capuani A; Russo R; Cappagli M; Poggi P; Leoncini R; Coli A; Duce T; Battistini S; Castellano A; Ragazzini G
    Minerva Cardioangiol; 1994; 42(1-2):11-20. PubMed ID: 8022540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New ways to scan the myocardium.
    Med Lett Drugs Ther; 1991 Sep; 33(853):87-9. PubMed ID: 1832204
    [No Abstract]   [Full Text] [Related]  

  • 55. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility.
    Bisi G; Sciagrà R; Santoro GM; Zerauschek F; Fazzini PF
    J Nucl Med; 1994 Aug; 35(8):1274-8. PubMed ID: 8046478
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-sestamibi and thallium-201.
    Di Rocco RJ; Rumsey WL; Kuczynski BL; Linder KE; Pirro JP; Narra RK; Nunn AD
    J Nucl Med; 1992 Jun; 33(6):1152-9. PubMed ID: 1534576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maldistribution of regional myocardial perfusion at rest in patients with coronary artery disease and no previous myocardial infarction, evidenced by 99mTc-Sestamibi scintigraphy.
    Marcassa C; Galli M; Parodi O; Marzullo P; Pirelli S; Inglese E; Giubbini R; Verna E; Santoro GM; Bisi G
    J Nucl Biol Med (1991); 1994 Sep; 38(3):495-501. PubMed ID: 7865546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Nuclear medical methods in cardiology].
    Mangschau A; Rootwelt K
    Tidsskr Nor Laegeforen; 1991 Feb; 111(6):681-4. PubMed ID: 2008686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of pharmacologic stimulation with myocardial perfusion scintigraphy in the evaluation of patients with ischemic cardiopathy].
    Abreu A; Pereira H; Ferreira R
    Rev Port Cardiol; 1992 Dec; 11(12):1101-4. PubMed ID: 1290655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined pharmacologic and exercise stress myocardial scintigraphy: a practical method for assessment of potential cardiac ischemia in patients with limited exercise capacity.
    Brooker JZ
    J S C Med Assoc; 1990 Mar; 86(3):143-7. PubMed ID: 2325371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.